Literature DB >> 20415296

Repeatability of retinal thickness measurements between spectral-domain and time-domain optical coherence tomography images in macular disease.

Amitha Domalpally1, Sapna Gangaputra, Qian Peng, Ronald P Danis.   

Abstract

BACKGROUND AND
OBJECTIVE: To evaluate and compare the intra-session repeatability of retinal thickness measurements from the Topcon 3D OCT 1000 (Topcon Medical Systems; Paramus, NJ), a spectral-domain optical coherence tomography (SD-OCT) system, with the Stratus (Carl Zeiss Meditec, Inc., Dublin, CA), a time-domain OCT (TD-OCT) system, in eyes with retinal diseases. PATIENTS AND METHODS: Repeated scans with both SD-OCT and TD-OCT were taken. Thickness measurements from high-quality scans were used to assess repeatability and compare measurements between the two instruments.
RESULTS: Paired scans from 127 eyes were evaluated, of which 63 pairs were of high quality. Coefficients of repeatability and variation for the central subfield were 20.1 μm (2.6%) with SD-OCT and 27.4 μm (4%) with TD-OCT (P = .38). The mean difference in central subfield thickness between the two instruments was 24.5 μm (standard deviation = 20.9).
CONCLUSION: Repeatability of retinal thickness measurements with the Topcon 3D OCT 1000 is comparable to the Stratus. The measurements of the two machines differ significantly and cannot be used interchangeably. Copyright 2010, SLACK Incorporated.

Entities:  

Mesh:

Year:  2010        PMID: 20415296     DOI: 10.3928/15428877-20100325-01

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  7 in total

1.  Effect of optical coherence tomography scan decentration on macular center subfield thickness measurements.

Authors:  Jeong W Pak; Ashwini Narkar; Sapna Gangaputra; Ronald Klein; Barbara Klein; Stacy Meuer; Yijun Huang; Ronald P Danis
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-02       Impact factor: 4.799

2.  Optical coherence tomography evaluation in the Multicenter Uveitis Steroid Treatment (MUST) trial.

Authors:  Amitha Domalpally; Michael M Altaweel; John H Kempen; Dawn Myers; Janet L Davis; C Stephen Foster; Paul Latkany; Sunil K Srivastava; Richard J Stawell; Janet T Holbrook
Journal:  Ocul Immunol Inflamm       Date:  2012-11-19       Impact factor: 3.070

3.  Importance of 3-D image reconstruction of spectral-domain OCT on outcome of grid laser photocoagulation for diffuse diabetic macular edema.

Authors:  Avinoam Ophir; Rana Hanna; Michael R Martinez
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

4.  Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema.

Authors:  Susan B Bressler; Allison R Edwards; Kakarla V Chalam; Neil M Bressler; Adam R Glassman; Glenn J Jaffe; Michele Melia; David D Saggau; Oren Z Plous
Journal:  JAMA Ophthalmol       Date:  2014-09       Impact factor: 7.389

Review 5.  Selective and complementary use of Optical Coherence Tomography and Fluorescein Angiography in retinal practice.

Authors:  Samir S Shoughy; Igor Kozak
Journal:  Eye Vis (Lond)       Date:  2016-10-17

6.  Measurable Range of Subfoveal Choroidal Thickness With Conventional Spectral Domain Optical Coherence Tomography.

Authors:  Mingui Kong; Da Ye Choi; Gyule Han; Yun-Mi Song; Sung Yong Park; Joohon Sung; Sungsoon Hwang; Don-Il Ham
Journal:  Transl Vis Sci Technol       Date:  2018-10-01       Impact factor: 3.283

7.  Agreement Between Spectral-Domain and Swept-Source Optical Coherence Tomography Retinal Thickness Measurements in Macular and Retinal Disease.

Authors:  Daren Hanumunthadu; Pearse A Keane; Konstantinos Balaskas; Adam M Dubis; Angelos Kalitzeos; Michel Michaelides; Praveen J Patel
Journal:  Ophthalmol Ther       Date:  2021-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.